Antibiotic Resistance In Health Care

A couple times a year local and national mass media put the spotlight on problems connected to antibiotic overuse. Some people consider those problems to be real and serious, and others think that the discussed topics are nothing more than new “fashionable” subjects to talk about, distracting people from “real” problems, such as climbing gas prices or war expenses. Meanwhile, antibiotic overuse continues as a common practice among US doctors and agribusinesses for the last 20 years. The practice of antibiotic overuse has put patient’s health at risk, contributed to antibiotic resistance and increased bacterial mutation to a new, stronger level; as well as it hitting the economy with new costly expenses in health care. It is time to stop

Throughout my life, adults have insisted the use of antibiotics to fight against the most inconsequential illnesses, whether it’s the cold or the flu. However, neither illness is due to invasion of bacteria. This misuse can lead to antibiotic resistance, also known as antimicrobial resistance(AMR), currently one of the central issues facing the public health system. While the process for antibiotic resistance occurs naturally through the process of adaptation, the mismanagement of antibiotic resources has accelerated the rate at which the bacteria adapt. The occurrence of this misinformation isn’t limited to a few adults: even some of my peers suggest taking antibiotics when faced with the flu. This leads to asking whether AMR is truly a problem and are present regulations enough to combat the issue.

Antibiotics are inarguably one of the greatest advances in medical science of the past century. Although the first natural antibiotic Penicillin was not discovered until 1928 by Scottish biologist Alexander Flemming, evidence exists that certain plant and mold growths were used to treat infections in ancient Egypt, ancient India, and classical Greece (Forrest, 1982). In our modern world with the advent of synthetic chemistry synthetic antibiotics like Erithromycin and its derivative Azithromycin have been developed. Antibiotics have many uses including the treatment of bacterial and protozoan infection, in surgical operations and prophylactically to prevent the development of an infection. Through these applications, antibiotics have saved countless lives across the world and radically altered the field of medicine. Though a wonderful and potentially lifesaving tool, antibiotic use is not without its disadvantages. Mankind has perhaps been too lax in regulation and too liberal in application of antibiotics and growing antibiotic resistance is the price we must now pay. A recent study showed that perhaps 70% of bacterial infections acquired during hospital visits in the United States are resistant to at least one class of antibiotic (Leeb, 2004). Bacteria are not helpless and their genetic capabilities have allowed them to take advantage of society’s overuse of antibiotics, allowing them to develop

Antibiotics differ from many other drugs in the fact that the treatment is for a very short time compared to drugs used to treat hypertension, diabetes, Parkinson’s, or cancer. The latter disorders have in common that the treatment, from the moment of diagnosis, is life-long. The treatment period for antibiotics is only a few weeks, making the return of investment poor. Increasing demands of authorities in both development and marketing phase and in legislation increase the costs of new antibiotics.[1] [3]

Research has revealed how overprescribing antibiotic creates several adverse outcomes, including the development of multidrug resistant organisms, Clostridium difficile infection, and increased costs of health care (Myung et al., 2015). The Consumer Report (2015) raised concern for the overuse of antibiotics and how it leads to the loss of the ability to treat serious infections. Doctors,

At least two million people are infected with antibiotic resistant superbugs and at least 23,000 die from them.

While stewardship is extremely important to slow the rate of resistance, we must also make sure that patients in need of antimicrobial therapy receive the treatment they need. Price of medication and overly cautious prescribers are two of many barriers that patients may experience; as clinicians it’s important that we do our part to promote appropriate and affordable treatments. Ideally, prescribers could determine the exact pathogen using a swab or culture of the infected tissue. This would prevent misdiagnoses and reduce unnecessary costs to the

Antibiotics-resistant organisms have become one of the most serious threats to public health, infecting over two million people and killing approximately 23,000 people annually.1 According to the CDC, “total inappropriate antibiotic use,” such as prescribing unnecessary antibiotics or giving the wrong dose or duration, makes up to 50% of all outpatient antibiotic use,2,3 and in 2009, the United States spent $10.7 billion on antibiotics, indicating that there is a lot of potential money to save.4

Overtime, antibiotics have been favorable as well as negligent to society. Antibiotic usage is helpful to society because it kills and fights off bacteria in both humans and animals. With an increase in antibiotic usage, these bacteria have become resistant to certain drugs which reduce the chance of the bacteria being killed off and result in bacteria multiplying, causing increased harm to the infected. According to Centers for Disease Control and Prevention (CDC, 2013), each year in the United States at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a result to these infections. Although multiple bacteria are antibiotic resistant, and those numbers will continue to rise, antibiotics should remain a staple in the treatment of diseases, as opposed to abandoning their use which will cause an increase in the prevalence of bacterial infections.

The increasing resistance of bacteria to antibiotics is a growing problem that affects individuals on a global status. Antibiotic resistance refers to the ability of bacteria to alter their genetic material and mutate to avoid destruction by antibiotic medications rendering the drugs ineffective in fighting infection and disease. This resistance has had tragic effects as numerous of the resistant infections have resulted in death of the host. Because of the severity of this condition, organizations and institutions across the globe have been working together to study and examine the best strategies to combat these resistant bacteria or sometimes referred to as “superbugs”. Many innovations have been proposed and implemented in attempts to rid people of their infections. The discussion of which approaches are the most effective and cost efficient has been taking place for decades and is still occurring today along with further investigations of alternatives to antibiotics altogether. Researchers are also attempting to understand what has caused the problem of antibiotic resistance and how this problem has developed. Efforts to contest these bacteria are extremely important and it is now up to the next generation of health care providers, researchers, and educators to implement the best ways to keep people healthy.

(2010) found that the treatment expenses related to methicillin resistance Staphylococcus aureus (MRSA) infection were significantly higher than those related to methicillin susceptible Staphylococcus aureus (MSSA) infection. For instance, they found that the average 6-month unadjusted costs for patients who had MRSA infection were $34,657, while the unadjusted costs for patients who had MSSA infection were $15,923. The expected reason for this matter is that patients infected with resistant infections might pay more extended hospital stays, laboratory tests, imaging tests, and for their expensive antibiotics such as intravenous antibiotics. Also, MRSA infection is more likely to infect blood stream and lungs, which is very dangerous and need extensive and expensive therapy. This financial burden might be very overwhelming for patients living in Low and/or Middle Income Countries (LMICs) and with low health insurance coverage and high out-of-pocket (OOP) expenditure. Knowing the overwhelming economic impact of antibiotic resistance is very important for policy makers and other stakeholders because they can develop strategies that reduce antibiotic resistance and therefore minimize the financial expenses of the

Dr. H. Scott Hurd, author of, “The Other Side of Antimicrobial Resistance” is writing to contradict thought that antibiotic-resistance is becoming a complete global threat. (2012) the article gives several counter claims that lead you in a different mindset than simply health care precautions. The author talks about foodborne illness been linked to antibiotic resistance in modern medicine, also about the important knowledge that can be taken away from antibiotics when researching HIV/AIDS, Methicillin-Resistant Staphylococcus Aureus (MRSA), and hospital-acquired infections through research and development. The author is showing the readers that there is another side, such as, not needing to be concerned about resistance to any antibiotics because scientist and others have an understanding of certain guidelines when it comes to the patients’ health. Therefore, each excuse people are giving to support the claim antibiotic-resistance is a threat to people. He states in his writing, “As soon as an antibiotic is first used, resistance begins to develop.” He is wanting to imply in his message that even though over-prescribing is a big factor, even as simple as the first time an antibiotic is prescribed it is having effects on the patient. However, according to the Mayo Clinic, in “Antibiotics: Misuse Puts You and Others at Risk” it infers the overuse or misuse of antibacterial drugs can make resistance develops even faster, causing an epidemic before scientists can find a

Infection is a major cause of human suffering. Even relatively minor infections can become more serious, leading to major infection and can, in some cases, lead to patient death. In addition to patient suffering, infection causes distress to family and friends.The costs to the health care system of providing care for those with infections are huge. In addition to concerns over the growing costs to health care, the use of antibiotics to treat these infections is thought to

The overuse of antibiotics has been a problem for well over a decade. This misuse leads to many nonvisible problems arising within the human population. As the use of antibiotics increases, the number of antibiotic resistant bacteria also increases. When bacteria become resistant to an antibiotic, another antibiotic must be used to try and kill it and the cycle becomes vicious. Michael Martin, Sapna Thottathil, and Thomas Newman stated that antimicrobial resistance is, “an increasingly serious threat to global public health that requires action across all government sectors and society” (2409).

According the World Health Organization (WHO), antibiotic resistance is one of the world’s greatest health threats to date (Haddox, 2013). In the article, The Health Threat of Antibiotic Resistance, Gail Haddox (2013) discusses the danger antibiotic resistance poses in today’s society and strategies to prevent the expansion of antibiotic resistance. In Europe alone, an estimated 25,000 deaths have been attributed to multi-resistant infections (Haddox, 2013). Common infections are now harder to treat due to the increased resistance to antibiotics across the world, in fact some are becoming untreatable. Antibiotics should be treated like oil, a non-renewable resource (Haddox, 2013).